Fingolimod is a first in class oral compound approved for the treatment of relapsing-remitting multiple sclerosis (RR-MS). The aim of this study was to evaluate clinical and neuroradiological responses to fingolimod as well as the safety and tolerability in RR-MS patients in clinical practice. In addition. a panel of pro-inflammatory serum cytokines was explored as potential biomarker... https://halohealthcarers.shop/product-category/shower-benches/